학술논문
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 11/1/2023, Vol. 41 Issue 31, p4864-4871, 9p
Subject
Language
ISSN
0732183X